Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Children (Basel, Switzerland)|April 3, 2021
Alleviating Terminal Pediatric Cancer PainKaren Moody, Mohammad Baig, Veronica CarulloJournal of Pain & Palliative Care Pharmacotherapy|November 3, 2015
Opioid-Induced Hyperalgesia: A Diagnostic DilemmaVeronica Carullo, Ingrid Fitz-James, Ellise DelphinBiomedicines|January 23, 2024
A Literature Review: The Mechanisms and Treatment of Neuropathic Pain-A Brief DiscussionRenira Rugnath, Casey Orzechowicz, Clayton Newell, et al.Expert Review of Hematology|October 3, 2022
Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?Raissa Nobrega, Veronica Carullo, Swee Lay Thein, et al.The Journal of Family Practice|March 20, 2015
Intrathecal analgesia: time to consider it for your patient?Naum Shaparin, Andrew Sim, Marco Pappagallo, et al.Pediatric Blood & Cancer|March 16, 2022
Demand-only patient-controlled analgesia for treatment of acute vaso-occlusive pain in sickle cell diseaseVeronica Carullo, Kerry Morrone, Meagan Weiss, et al.Journal of Pain and Symptom Management|February 14, 2017
A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive CrisisKaren Moody, Bess Abrahams, Rebecca Baker, et al.Journal of Pediatric Psychology|November 8, 2024
Temporal summation of pain in sickle cell disease: comparison of adolescents and young adults with chronic vs. infrequent painCynthia Karlson, Harrison Dickens, Wynette Williams-Kirkwood, et al.Complementary Therapies in Medicine|September 21, 2020
Randomized phase 2 trial of Intravenous Gamma Globulin (IVIG) for the treatment of acute vaso-occlusive crisis in patients with sickle cell disease: Lessons learned from the midpoint analysisDeepa Manwani, Chunliang Xu, Sung Kyun Lee, et al.American Journal of Hematology|January 24, 2015
Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisisDeepa Manwani, Grace Chen, Veronica Carullo, et al.Pageof 1